These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8540925)

  • 1. [Immunohistochemistry in liver pathology].
    Selves J; Voigt JJ; Reynes M
    Ann Pathol; 1995; 15(5):388-95. PubMed ID: 8540925
    [No Abstract]   [Full Text] [Related]  

  • 2. Peroxisomes (microbodies) in cell pathology.
    Goldfischer S; Reddy JK
    Int Rev Exp Pathol; 1984; 26():45-84. PubMed ID: 6400515
    [No Abstract]   [Full Text] [Related]  

  • 3. [Expressions of breast cancer metastasis suppressor-1 and heparanase in primary hepatocellular carcinoma and chronic liver diseases and the clinicopathological significances].
    Zeng XB; Yang ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):870-2. PubMed ID: 22553846
    [No Abstract]   [Full Text] [Related]  

  • 4. Histologic typing of liver tumors of the rat. Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences, Washington, D.C.
    J Natl Cancer Inst; 1980 Jan; 64(1):177-206. PubMed ID: 6986002
    [No Abstract]   [Full Text] [Related]  

  • 5. [Differential diagnosis of liver metastases. Imitation by foreign body granulomas (raspberry pits)].
    Mühe E; Gerlach D; Hermanek P
    Munch Med Wochenschr; 1971 Oct; 113(42):1376-8. PubMed ID: 5171189
    [No Abstract]   [Full Text] [Related]  

  • 6. Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer.
    Moon YW; Rha SY; Zhang X; Jeung HC; Yang WI; Kwon O; Jeong JH; Cheon SH; Yoo NC; Chung HC
    J Surg Oncol; 2009 Nov; 100(6):459-65. PubMed ID: 19598149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proteoglycans in the liver].
    Kovalszky I; Dudás J; Gallai M; Hollósi P; Tátrai P; Tátrai E; Schaff Z
    Magy Onkol; 2004; 48(3):207-13. PubMed ID: 15520870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undifferentiated embryonal sarcoma of the liver in childhood.
    Mistry RC; Deshpande RK; Chinoy R; Sampat M; Desai PB
    Indian J Cancer; 1995 Dec; 32(4):175-8. PubMed ID: 8772820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin immunohistochemistry in liver histopatology.
    Van Eyken P
    Adv Clin Path; 2000 Oct; 4(4):201-11. PubMed ID: 11436159
    [No Abstract]   [Full Text] [Related]  

  • 10. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and recurrent embryonal sarcoma of the liver: clinicopathological and immunohistochemical analysis.
    Zheng JM; Tao X; Xu AM; Chen XF; Wu MC; Zhang SH
    Histopathology; 2007 Aug; 51(2):195-203. PubMed ID: 17573940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of fibronectin and CD44v6 expression with invasive growth and metastasis of liver cancer.
    Jha RK; Ma Q; Chen S; Sha H; Ding S
    Cancer Invest; 2009 Mar; 27(3):324-8. PubMed ID: 19194823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Special issue of pathology of liver].
    Voigt JJ; Bedossa P
    Ann Pathol; 1995; 15(5):313-5. PubMed ID: 8540915
    [No Abstract]   [Full Text] [Related]  

  • 14. Active cell death (apoptosis) in liver biology and disease.
    Schulte-Hermann R; Bursch W; Grasl-Kraupp B
    Prog Liver Dis; 1995; 13():1-35. PubMed ID: 9224496
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
    Iavarone M; Lampertico P; Seletti C; Francesca Donato M; Ronchi G; del Ninno E; Colombo M
    Cancer; 2003 Aug; 98(3):529-34. PubMed ID: 12879470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
    Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with metastatic cancer of unknown primary.
    Ghosh L; Dahut W; Kakar S; Posadas EM; Torres CG; Cancel-Santiago R; Ghosh BC
    Curr Probl Surg; 2005 Jan; 42(1):12-66. PubMed ID: 15711508
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroendocrine cell differentiation of poorly differentiated colorectal adenocarcinoma correlates with liver metastasis.
    Shinji S; Naito Z; Ishiwata T; Tanaka N; Furukawa K; Suzuki H; Seya T; Kan H; Tsuruta H; Matsumoto S; Matsuda A; Teranishi N; Ohaki Y; Tajiri T
    Int J Oncol; 2006 Aug; 29(2):357-64. PubMed ID: 16820877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Why radiological diagnosis of liver tumors?].
    Schareck WD
    Radiologe; 1995 Nov; 35(11 Suppl 2):S271-4. PubMed ID: 8588034
    [No Abstract]   [Full Text] [Related]  

  • 20. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
    Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
    Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.